tiprankstipranks
Clinigence Holdings (NUTX)
NASDAQ:NUTX
US Market

Clinigence Holdings (NUTX) Technical Analysis

Compare
203 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Clinigence Holdings’s (NUTX) Moving Averages Convergence Divergence (MACD) indicator is 6.51, suggesting Clinigence Holdings is a Buy.
Clinigence Holdings’s (NUTX) 20-Day exponential moving average is 55.09, while Clinigence Holdings’s (NUTX) share price is $57.6, making it a Buy.
Clinigence Holdings’s (NUTX) 50-Day exponential moving average is 45.45, while Clinigence Holdings’s (NUTX) share price is $57.6, making it a Buy.

Clinigence Holdings (NUTX) Pivot Points

Feb 23, 2025, 02:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
55.30
58.02
59.84
62.56
64.38
67.10
68.92
Fibonacci
58.02
59.76
60.83
62.56
64.30
65.37
67.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Clinigence Holdings (NUTX) Moving Averages

Feb 23, 2025, 02:49 AM
Period
Simple
Exponential
MA5
63.21Sell
61.29Sell
MA10
61.02Sell
60.00Sell
MA20
54.41Buy
55.09Buy
MA50
41.96Buy
45.45Buy
MA100
34.41Buy
37.09Buy
MA200
22.83Buy
26.35Buy
Clinigence Holdings’s (NUTX) 10-Day exponential moving average is 60.00, while Clinigence Holdings’s (NUTX) share price is $57.6, making it a Sell.
Clinigence Holdings’s (NUTX) 100-Day exponential moving average is 37.09, while Clinigence Holdings’s (NUTX) share price is $57.6, making it a Buy.
Clinigence Holdings’s (NUTX) stock price is $57.6 and Clinigence Holdings’s (NUTX) 50-day simple moving average is 41.96, creating a Buy signal.
Clinigence Holdings’s (NUTX) stock price is $57.6 and Clinigence Holdings’s (NUTX) 100-day simple moving average is 34.41, creating a Buy signal.
Clinigence Holdings’s (NUTX) stock price is $57.6 and Clinigence Holdings’s (NUTX) 200-day simple moving average is 22.83, creating a Buy signal.

Clinigence Holdings (NUTX) Technical Indicators

Feb 23, 2025, 02:49 AM
Name
Value
Implied Action
RSI (14)
58.19
Neutral
STOCH (9,6)
52.28
Neutral
STOCHRSI (14)
68.03
Neutral
MACD (12,26)
6.51
Buy
ADX (14)
31.07
Neutral
Williams %R
-46.73
Buy
CCI (14)
40.57
Neutral
ATR (14)
4.61
-
Ultimate Oscillator
56.45
Neutral
ROC
20.93
Buy
Clinigence Holdings’s (NUTX) Relative Strength Index (RSI) is 58.19, creating a Neutral signal.
Clinigence Holdings’s (NUTX) Trend Strength Indicator (ADX) is 31.07, creating a Neutral signal.
Clinigence Holdings’s (NUTX) Commodity Channel Index (CCI) is 40.57, creating a Neutral signal.
Clinigence Holdings’s (NUTX) Price Rate of Change (ROC) is 20.93, creating a Buy signal.

FAQ

Is NUTX a Buy, Hold, or Sell?
Based on NUTX’s technical indicators, NUTX is a Buy.
    What is NUTX’s RSI (14)?
    NUTX’s RSI (14) is 58.19, which suggests NUTX is a Neutral.
      What is NUTX’s MACD?
      NUTX’s MACD is 6.51, which suggests NUTX is a Buy.
        What is NUTX’s 5-day moving average?
        NUTX’s 5-day moving average is 63.21, which suggests NUTX is a Sell.
          What is NUTX’s 20-day moving average?
          NUTX 20-day moving average is 54.41, which suggests NUTX is a Buy.
            What is NUTX’s 50-day moving average?
            NUTX’s 50-day moving average is 41.96, which suggests NUTX is a Buy.
              What is NUTX’s 200-day moving average?
              NUTX’s 200-day moving average is 22.83, which suggests NUTX is a Buy.
                What is NUTX’s Williams % R (14)?
                NUTX’s Williams % R (14) is -46.73, which suggests NUTX is a Buy.
                  What is NUTX’s CCI (14)?
                  NUTX’s CCI (14) is 40.57, which suggests NUTX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis